» Articles » PMID: 37711153

Metformin-induced Activation of Ca Signaling Prevents Immune Infiltration/pathology in Sjogren's Syndrome-prone Mouse Models

Overview
Date 2023 Sep 15
PMID 37711153
Authors
Affiliations
Soon will be listed here.
Abstract

Immune cell infiltration and glandular dysfunction are the hallmarks of autoimmune diseases such as primary Sjogren's syndrome (pSS), however, the mechanism(s) is unknown. Our data show that metformin-treatment induces the salivary glands of IL14α-transgenic mice (IL14α), which is a model for pSS. Mechanistically, we show that loss of in IL14α mice. Furthermore, the loss of Finally, restoration of metformin-induced inhibited the release of alarmins and prevented the activation of ER stress that was essential for immune cell infiltration. These results suggest that loss of metformin-mediated activation of signaling prevents ER stress, which inhibited the release of alarmins that induces immune cell infiltration leading to salivary gland dysfunction observed in pSS.

Citing Articles

Updating on the Dual Role of Salivary Gland Epithelial Cell (SGEC) in Sjögren's Disease.

Zhu W, Lu Y, Zhu Y, Huang X, Wang Y J Inflamm Res. 2025; 18:3039-3053.

PMID: 40046682 PMC: 11881760. DOI: 10.2147/JIR.S509220.


Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway.

Park J, Jung K, Jia D, Yang S, Attri K, Ahn S Cell Rep Med. 2025; 6(2):101941.

PMID: 39933530 PMC: 11866546. DOI: 10.1016/j.xcrm.2025.101941.


Bibliometric analysis of metformin as an immunomodulator (2013-2024).

Zhou T, Yu Y, Li L, Liu X, Xiang Q, Yu R Front Immunol. 2025; 15():1526481.

PMID: 39845945 PMC: 11750822. DOI: 10.3389/fimmu.2024.1526481.


Immunomodulatory Effects of SGLT2 Inhibitors and Metformin in Managing Rheumatic Diseases: A Narrative Review.

Nallathambi N, Bisaralli R, Mamadapur M Mediterr J Rheumatol. 2024; 35(3):411-421.

PMID: 39463877 PMC: 11500115. DOI: 10.31138/mjr.010324.ies.

References
1.
Selvaraj S, Sun Y, Watt J, Wang S, Lei S, Birnbaumer L . Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling. J Clin Invest. 2012; 122(4):1354-67. PMC: 3314472. DOI: 10.1172/JCI61332. View

2.
Chiorini J, cihakova D, Ouellette C, Caturegli P . Sjögren syndrome: advances in the pathogenesis from animal models. J Autoimmun. 2009; 33(3-4):190-6. PMC: 3439154. DOI: 10.1016/j.jaut.2009.09.009. View

3.
Kim J, Kim Y, Park S . Metformin as a Treatment Strategy for Sjögren's Syndrome. Int J Mol Sci. 2021; 22(13). PMC: 8269365. DOI: 10.3390/ijms22137231. View

4.
Madiraju A, Erion D, Rahimi Y, Zhang X, Braddock D, Albright R . Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014; 510(7506):542-6. PMC: 4074244. DOI: 10.1038/nature13270. View

5.
Ursini F, Russo E, Pellino G, DAngelo S, Chiaravalloti A, De Sarro G . Metformin and Autoimmunity: A "New Deal" of an Old Drug. Front Immunol. 2018; 9:1236. PMC: 5994909. DOI: 10.3389/fimmu.2018.01236. View